Evidence map›Paper›PMID 30474116›Full record

ReviewInternational journal of cancer2019

The role of microbiota in the development of colorectal cancer.

Zhujiang Dai, Jingqiu Zhang, Qi Wu, Juan Chen, Jun Liu, Lu Wang, Chaowu Chen, Jiaming Xu, Hongpeng Zhang, Chunfeng Shi and 5 more

Open access · bronzeAbstract readReview
In one paragraph

Review in International journal of cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 2 syntheses or guidelines pooled it, 125 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. EClinicalMedicine · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Correlations for untargeted GC × GC-HRTOF-MS metabolomics of colorectal cancer.Metabolomics : Official journal of the Metabolomic Society · 2023
    Article
  20. Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Zhujiang DaiClinical Medical College, Yangzhou University, Yangzhou, Jiangsu Province, China.
Jingqiu ZhangDepartment of General Surgery, Institute of General Surgery, Clinical Medical College, Yangzhou University, Northern Jiangsu People's Hospital, Yangzhou, China.
Qi WuClinical Medical College, Yangzhou University, Yangzhou, Jiangsu Province, China.
Juan ChenDepartment of Gastroenterology, Clinical Medical College, Yangzhou University, Northern Jiangsu People's Hospital, Yangzhou, China.
Jun LiuDepartment of Gastroenterology, Clinical Medical College, Yangzhou University, Northern Jiangsu People's Hospital, Yangzhou, China.
Lu WangDepartment of Gastroenterology, Clinical Medical College, Yangzhou University, Northern Jiangsu People's Hospital, Yangzhou, China.
Chaowu ChenDepartment of Gastroenterology, Clinical Medical College, Yangzhou University, Northern Jiangsu People's Hospital, Yangzhou, China.
Jiaming XuDepartment of General Surgery, Institute of General Surgery, Clinical Medical College, Yangzhou University, Northern Jiangsu People's Hospital, Yangzhou, China.
Hongpeng ZhangDepartment of General Surgery, Institute of General Surgery, Clinical Medical College, Yangzhou University, Northern Jiangsu People's Hospital, Yangzhou, China.
Chunfeng ShiClinical Medical College, Yangzhou University, Yangzhou, Jiangsu Province, China.
Zhen LiClinical Medical College, Yangzhou University, Yangzhou, Jiangsu Province, China.
Huiwen FangClinical Medical College, Yangzhou University, Yangzhou, Jiangsu Province, China.
Chaobiao LinClinical Medical College, Yangzhou University, Yangzhou, Jiangsu Province, China.
Dong TangDepartment of General Surgery, Institute of General Surgery, Clinical Medical College, Yangzhou University, Northern Jiangsu People's Hospital, Yangzhou, China.ORCID 0000-0002-4372-9972
Daorong WangDepartment of General Surgery, Institute of General Surgery, Clinical Medical College, Yangzhou University, Northern Jiangsu People's Hospital, Yangzhou, China.
Northern Jiangsu People's Hospital · CNYangzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer is the third largest cancer in worldwide and has been proven to be closely related to the intestinal microbiota. Many reports and clinical studies have shown that intestinal microbial behavior may lead to pathological changes in the host intestines. The changes can be divided into epigenetic changes and carcinogenic changes at the gene level, which ultimately promote the production and development of colorectal cancer. This article reviews the pathways of microbial signaling in the intestinal epithelial barrier, the role of microbiota in inflammatory colorectal tumors, and typical microbial carcinogenesis. Finally, by gaining a deeper understanding of the intestinal microbiota, we hope to achieve the goal of treating colorectal cancer using current microbiota technologies, such as fecal microbiological transplantation.

Indexed as

CarcinogenesisColorectal NeoplasmsEpigenesis, GeneticFecal Microbiota TransplantationFecesGastrointestinal MicrobiomeHost-Pathogen InteractionsHumansIntestinesMicrobiotacarcinogenesiscolorectal cancerinflammationmicrobiota

Identifiers

PMID30474116
PMCPMC6899977
OpenAlexW2902972083

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.